Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Treatment of plaque psoriasis with deucravacitinib (POETYK PSO-2 study): a plain language summary.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Treatment of plaque psoriasis with deucravacitinib (POETYK PSO-2 study): a plain language summary.
Treatment of plaque psoriasis with deucravacitinib (POETYK PSO-2 study): a plain language summary. Immunotherapy. 2023 08; 15(11):787-797.
View in:
PubMed
subject areas
Adult
Clinical Trials, Phase III as Topic
Humans
Psoriasis
Skin
Thalidomide
Treatment Outcome
authors with profiles
Kenneth Gordon